SWTX - SpringWorks Therapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5565
Avg. Estimate-1.26-1.22-4.94-4.21
Low estimate-1.33-1.36-5.98-5.16
High estimate-1.18-1.11-4.21-3.31
Year ago EPS-1.41-1.37-5.21-4.94
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5575
Avg. EstimateN/A2.55M13.12M64.13M
Low estimateN/AN/A1.15M37.58M
High estimateN/A6M49M101M
Year ago salesN/AN/AN/A13.12M
Sales growth (year/est)N/AN/AN/A388.80%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-1.2-1.32-1.22-1.25
Actual EPS-1.41-1.37-1.17-1.18
Difference-0.21-0.050.050.07
Surprise %-17.50%-3.80%4.10%5.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-1.26-1.22-4.94-4.21
7 days ago-1.26-1.22-4.94-4.21
30 days ago-1.31-1.28-5.12-3.87
60 days ago-1.29-1.21-5.07-4.07
90 days ago-1.23-1.16-4.82-3.94
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2221
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesSWTXIndustrySector(s)S&P 500
Current qtr.10.60%N/AN/AN/A
Next qtr.10.90%N/AN/AN/A
Current year5.20%N/AN/AN/A
Next year14.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A